Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

KIT's ship comes in.

Braun BS.

Blood. 2012 Sep 27;120(13):2541-2. No abstract available.

2.
3.

c-kit Point mutation in patients with myeloproliferative disorders.

Kimura A, Nakata Y, Katoh O, Hyodo H.

Leuk Lymphoma. 1997 Apr;25(3-4):281-7. Review.

PMID:
9168438
4.

The tyrosine phosphatase Shp2 (PTPN11) in cancer.

Chan G, Kalaitzidis D, Neel BG.

Cancer Metastasis Rev. 2008 Jun;27(2):179-92. doi: 10.1007/s10555-008-9126-y. Review.

PMID:
18286234
5.

Effects of mutant c-Kit in early myeloid cells.

Ashman LK, Ferrao P, Cole SR, Cambareri AC.

Leuk Lymphoma. 1999 Aug;34(5-6):451-61. Review. Corrected and republished in: Leuk Lymphoma. 2000 Mar;37(1-2):233-43.

PMID:
10492068
6.

Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.

Roskoski R Jr.

Biochem Biophys Res Commun. 2005 Nov 11;337(1):1-13. Review.

PMID:
16129412
7.

c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

Boissan M, Feger F, Guillosson JJ, Arock M.

J Leukoc Biol. 2000 Feb;67(2):135-48. Review.

PMID:
10670573
8.

Role of germline genetic factors in MPN pathogenesis.

Harutyunyan AS, Kralovics R.

Hematol Oncol Clin North Am. 2012 Oct;26(5):1037-51. doi: 10.1016/j.hoc.2012.07.005. Epub 2012 Aug 21. Review.

PMID:
23009936

Supplemental Content

Support Center